Ipratropium HFA Inhaler Information
The ipratropium HFA inhaler (Atrovent® HFA) is used to treat chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. Unlike older inhalers, this product uses an environmentally friendly hydrofluoroalkane (HFA) propellant, a substance that does not deplete the ozone layer.
This medication is usually taken four times a day. It comes in a metered-dose inhaler (called an "MDI"), and does not need to be shaken before use. Upper respiratory tract infections, sinus infections, and worsening of COPD are some of the drug's potential side effects.
If you have certain other medical conditions, such as glaucoma or an enlarged prostate, your healthcare provider needs to know this information when prescribing this drug. Ipratropium HFA may not be appropriate in these situations, and discussing these and other issues with your healthcare provider will help ensure the safety and effectiveness of your treatment plan.
(For more info, click Ipratropium HFA Inhaler. This article gives a comprehensive overview of this medication, including a discussion on how it works, available strengths, overdose symptoms, and more.)